Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.

This relationship was highly significant in patients with a disease duration of less than 5 years (n = 19, p = 0.003) and in patients treated with IFN-β for less than two years (n = 21, p = 0.004) ( Figure 2 ).

also in 132,142 other papers